RxDoctor Payments Data

Kimberly Smith

Family · Carrollton, KYNPI 1508411562

Payments from drug & device makers

$2,710in general payments, 2019–2025

Across 159 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$929
  • Novo Nordisk$230
  • Amgen$199
  • Lilly USA, LLC$171
  • Novartis$130
  • Bayer$124
  • plus $928 from 20 others

What the payments were for

  • Food & beverage$2,710100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,710 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl12$37,317
OzempicSemaglutide14$30,954
MyrbetriqMirabegron12$13,542
FarxigaDapagliflozin Propanediol13$11,865
Aimovig AutoinjectorErenumab-Aooe12$8,869
Buspirone Hcl23$561
Atorvastatin Calcium67$461
Albuterol Sulfate HfaAlbuterol Sulfate17$446
Methocarbamol26$422
Omeprazole20$410
Amitriptyline Hcl17$281
Ezetimibe34$249
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$231
Pramipexole DihydrochloridePramipexole Di-Hcl13$198
Tizanidine Hcl13$169

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$929$37,31712 claims
Novo NordiskOzempic$230$30,95414 claims
Astellas Pharma US IncMyrbetriq$31$13,54212 claims
AstraZenecaFarxiga$104$11,86513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Carrollton

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →